Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome

dc.contributor.author	Bernal del Castillo, Teresa
dc.contributor.author	Díez Campelo, María
dc.contributor.author	Godoy, Vicky
dc.contributor.author	Rojas, Silvia
dc.contributor.author	Colado Varela, Enrique
dc.contributor.author	Luño Fernández, Elisa
dc.date.accessioned	2014-04-21T08:07:20Z
dc.date.available	2014-04-21T08:07:20Z
dc.date.issued	2014
dc.identifier.citation	Leukemia Research, 38(5), p. 551–556 (2014); doi:10.1016/j.leukres.2014.02.001	spa
dc.identifier.issn	0145-2126
dc.identifier.issn	1873-5835
dc.identifier.uri	http://hdl.handle.net/10651/25546
dc.description.statementofresponsibility	Bernal, T., Diez-Campelo, M., Godoy, V., Rojas, S., Colado, E., Alcoceba, M., González, M., Vidriales, B., Sánchez-Guijo, F.M., López-Corral, L., Luño, E., Del Cañizo, C.
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartof	Leukemia Research, 38(5)	spa
dc.rights	© Elsevier
dc.title	Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome	spa
dc.type	journal article
dc.identifier.doi	10.1016/j.leukres.2014.02.001
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.leukres.2014.02.001

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.